Ken Griffin Infu System Holdings, Inc Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.8 - $6.95 $2,320 - $2,780	400 Added 26.67%	1,900 $12,000
Q2 2024 Aug 14, 2024	SELL	$6.34 - $8.81 $64,034 - $88,981	-10,100 Reduced 87.07%	1,500 $10,000
Q1 2024 May 15, 2024	BUY	$8.51 - $10.19 $38,295 - $45,855	4,500 Added 63.38%	11,600 $99,000
Q4 2023 Feb 14, 2024	SELL	$8.59 - $10.89 $3,436 - $4,356	-400 Reduced 5.33%	7,100 $74,000
Q3 2023 Nov 14, 2023	SELL	$9.58 - $11.25 $87,178 - $102,375	-9,100 Reduced 54.82%	7,500 $72,000
Q2 2023 Aug 14, 2023	BUY	$7.68 - $10.44 $96,000 - $130,500	12,500 Added 304.88%	16,600 $159,000
Q1 2023 May 15, 2023	SELL	$6.9 - $10.77 $6,900 - $10,770	-1,000 Reduced 19.61%	4,100 $31,000
Q4 2022 Feb 14, 2023	BUY	$6.96 - $9.27 $35,496 - $47,277	5,100 New	5,100 $44,000

14.3M

1.9K

600

Ticker INFU
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 20,694,800
Market Cap $183M
Description
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.